---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-005586"
form_type: "8-K"
ticker: "BCYC"
cik: "0001761612"
company_name: "BICYCLE THERAPEUTICS PLC"
filed_at: "2023-01-23T23:59:59+00:00"
generated_at: "2026-06-20T11:54:38.370972+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bicycle Therapeutics increases change-in-control severance for CEO, CFO, and CTO

## Summary
- CEO Kevin Lee receives 24 months' base salary and benefits on change-of-control termination; subject to shareholder approval.
- CFO Lee Kalowski and CTO Michael Skynner get 18 months' base salary and benefits on change-of-control termination.
- Compensation committee approved amendments on Jan 17, 2023; CEO amendment pending AGM vote.

## SEC filing metadata
- accession: 0001104659-23-005586
- form_type: 8-K
- ticker: BCYC
- cik: 0001761612
- company_name: BICYCLE THERAPEUTICS PLC
- filed_at: 2023-01-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1761612/000110465923005586/0001104659-23-005586-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1761612/000110465923005586/tm234142d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-005586
- JSON: https://secwatch.observer/filing/0001104659-23-005586.json
- Plain text: https://secwatch.observer/filing/0001104659-23-005586.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.